Fwd: GIZ giz-health> Invitation: Pricing and Availability of locallyproduced and imported medicines in Kenya
Daniel Molokele
From: Heineke, Corinna GIZ <corinna...@giz.de>
Date: 19 March 2018 at 19:17
Subject: GIZ giz-health> Invitation: Pricing and Availability of locallyproduced and imported medicines in Kenya
To: "Rabien, Dirk GIZ" <dirk....@giz.de>, "Hiller, Kina-Kira GIZ" <kina-kir...@giz.de>, Marg Ewen <Ma...@haiweb.org>, "Richter-Airijoki,Heide GIZ KE" <heide.richt...@giz.de>, "Walter, Thomas(Thomas...@gfa-group.de)" <Thomas...@gfa-group.de>, "Kiplangat-Ronoh,Wesley (wesley...@gfa-group.de)" <wesley...@gfa-group.de>, "HASAN,Shahid (Shahid...@unido.org)" <Shahid...@unido.org>, Juergen REINHARDT <J.Rei...@unido.org>, "Ermias Biadgleng (Ermias.B...@unctad.org)" <Ermias.B...@unctad.org>, Christoph Spennemann <Christoph....@unctad.org>, "Christina Förg-Wimmer (c.f...@gmx.de)" <c.f...@gmx.de>, "Tobias.D...@ptb.de" <Tobias.D...@ptb.de>, "Tobias Bünder (tobias...@gmail.com)" <tobias...@gmail.com>, "Grimm, Susanne GIZ TZ" <susann...@giz.de>, "Hoecker, Ulrich GIZ" <ulrich....@giz.de>, "Wendt, Felix Maximilian GIZ" <felix...@giz.de>, "Zehentner-Capell, Daniela" <Daniela.Zehe...@bmz.bund.de>, "Burger, Gina" <Gina....@bmz.bund.de>, "roland....@bmz.bund.de" <roland....@bmz.bund.de>, "Kuhn, Imke" <Imke...@bmz.bund.de>, "Holtmeier, Frank GIZ KE" <frank.h...@giz.de>, "Le Mentec, Rozenn CIM-IFTZ" <rozenn....@cimonline.de>, "Christoph...@medeor.org" <Christoph...@medeor.org>, "Buchkremer, Irmgard(Irmgard.B...@medeor.de)" <Irmgard.B...@medeor.de>, "Tesch,Christina GIZ" <christi...@giz.de>, "Elser, Jeanette GIZ" <jeanett...@giz.de>, "giz-h...@mailserv.giz.de" <giz-h...@mailserv.giz.de>, "Aehling, Dorothee GIZ" <dorothee...@giz.de>
This message is eligible for Automatic Cleanup! (Invitation
Measuring and comparing the price and availability of locally produced and imported medicines in Kenya
Presentation of the study results
Date & Time: 28 March 2018, 1 pm CET
Health is a human right and the provision of medicines is a fundamental component of healthcare. Ensuring access to medicines requires policies to improve the availability and affordability of quality-assured medicines that meet local health needs. However, surveys using the World Health Organization (WHO)/Health Action International (HAI) medicine price and availability tool have often found poor availability (particularly in the public sector), high prices in both public and private sectors, and unaffordable treatments for those on low wages.
Increasingly, governments in low- and middle-income countries (LMIC) are supporting the local production of medicines, expecting that it will result in increased availability and lower prices, as well as industrial and economic benefits. But little is known about the impact of local production on medicine prices and availability. In 2013/14, HAI and WHO therefore developed a methodology to measure and compare the prices and availability of locally produced and imported medicines.
The GIZ Global Project “Access to Medicines” actively supports the development of local pharmaceutical production in several low- and middle-income countries, including Kenya where the support has been provided for close to twelve years. Kenya is actively building its local pharmaceutical industry and is thought to have more than 40 registered local medicine manufacturers. The government has a local preference of up to 15% when buying locally produced medicines, and offers other forms of support to local medicine manufacturers in the form of tax and duty exemptions.
GIZ and HAI thus cooperated to measure and compare prices and availability of locally produced and imported medicines in Kenya. The aim of the study was to inform discussions on whether the support given to local pharmaceutical manufacturers by the government, GIZ and others has resulted in higher availability and lower prices for medicines in healthcare facilities and pharmacies. The survey collected data at 25 medicine outlets in the public, private and faith-based sectors in six counties.
We look forward to welcoming the author of the study, Margaret Ewen, PhD, Senior Project Manager at Health Action International, who will present the study findings and their implications.
.........................................................................................................................................
à An Skype-Besprechung teilnehmen
Falls Sie Schwierigkeiten bei der Teilnahme haben, bitte Skype Web App ausprobieren
Per Telefon teilnehmen
+496196794018 (Deutschland) Deutsch (Deutschland)
Konferenzkennung: 17990127
PIN für Einwahl vergessen? |Hilfe
[!OC([0407])!]
.........................................................................................................................................
Corinna Heineke
Head
Global Project ‚Access to Medicines‘
Unit ‚Sustainable Economic Development, Digitalisation‘
Division ‚Economic and Social Development, Digitalisation‘
Deutsche Gesellschaft für
Internationale Zusammenarbeit (GIZ) GmbH
Köthener Strasse 2
10963 Berlin
Germany
F +49 30 33842422-316
S corihei (Skype)
Deutsche Gesellschaft fuer Internationale Zusammenarbeit (GIZ) GmbH;
Sitz der Gesellschaft Bonn und Eschborn/Registered offices Bonn and Eschborn, Germany;
Registergericht/Registered at Amtsgericht Bonn, Germany; Eintragungs-Nr./Registration no. HRB 18384 und/and Amtsgericht Frankfurt am Main, Germany; Eintragungs-Nr./Registration no. HRB 12394;
USt-IdNr./VAT ID no. DE 113891176;
Vorsitzender des Aufsichtsrats/Chairman of the Supervisory Board: Dr. Friedrich Kitschelt, Staatssekretaer/State Secretary;
Vorstand/Management Board: Tanja Goenner (Vorstandssprecherin/Chair of the Management Board), Dr. Christoph Beier (Stellv. Vorstandssprecher/Vice-Chair of the Management Board), Dr. Hans-Joachim Preuss
_______________________________________________
giz-health mailing list
giz-h...@mailserv.giz.de
https://mailserv.giz.de/listinfo/giz-health